Changes in CEVEC’s Supervisory Board

04-Jan-2011 - Germany

CEVEC Pharmaceuticals announced that Rainer Christine has joined its supervisory board. Rainer Christine was the CEO and co-founder of the German-American biotools company amaxa and plays an active role in the life sciences related venture capital industry. Under Rainer’s leadership amaxa grew from start-up in 1998 to a full-fledged and profitable life science company with strong scientific and commercial activities, 160 staff in Europe and the US, and more than EUR 100 million in cumulative sales. In 2008, amaxa was successfully sold to Lonza, a global supplier to the life-science industry.

At the same time, Gangolf Ehlen, previous Chairman of CEVEC’s supervisory board and lead investor from Venture Capital Beteiligungen Sparkasse KölnBonn, will resign from the CEVEC board to pursue a new role at Sparkasse KölnBonn. New chairman of the board will be the current vice-chairman Karlheinz Schmelig, Managing Partner at current lead investor Creathor Venture.

The CEVEC supervisory board changes are accompanied by the successful first closing of a further financing round to expand CEVECs vaccine platform business.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances